Improving Hypertension Control in Rheumatoid Arthritis

Официальное название

Improving Hypertension Control for Patients With Rheumatoid Arthritis

Обзор

Rheumatoid arthritis (RA) is a autoimmune disease associated with an increased risk of developing coronary artery disease (CAD) and premature death,. Traditional CAD risk factors like hypertension (HTN) are both very common and poorly controlled among RA patients. Patients with RA face significant challenges in controlling HTN. The goal of this project is to identify barriers to HTN care in patients with RA to reduce CAD events.

Вмешательства

• Поведенческое Blood pressure intervention arm
  The intervention will focus on empowering patients to actively participate in their HTN care, facilitating patient-provider communication, and creating a cohesive care team to close the coordination loop for HTN management. This pilot intervention will help achieve these goals by providing participants with home blood pressure monitors and teaching, improving patient-provider communication regarding blood pressure and RA management, and initiating care coordination between rheumatology and prima

Первичные конечные точки

• Intervention feasibility as measured by participant accrual rates [Срок оценки: 6 months]
• Intervention feasibility as measured by participant retention [Срок оценки: 6 months]
• Intervention feasibility as measured by adherence to blood pressure monitoring [Срок оценки: 6 months]
• Intervention feasibility as measured by adherence to survey reporting [Срок оценки: 6 months]
• Intervention feasibility as measured by sample characteristics [Срок оценки: 6 months]
• Intervention feasibility as measured by use of resources [Срок оценки: 6 months]
• Intervention feasibility as measured by sustainability of data collection procedures [Срок оценки: 6 months]
• Intervention acceptability as measured by qualitative interviews [Срок оценки: 6 months]
• Perceived appropriateness of the intervention to address the health care disparity in HTN (hypertension) control for Black RA patients as measured by qualitative interviews [Срок оценки: 6 months]
• Barriers to and enablers of participating in the intervention as measured by qualitative interviews [Срок оценки: 6 months]

Вторичные конечные точки (9)

• Participant blood pressure values [Срок оценки: 6 months]
• Participant rheumatoid arthritis disease activity [Срок оценки: 6 months]
• Participant medication use [Срок оценки: 6 months]
• Anti-hypertensive medication adherence [Срок оценки: 6 months]
• Perceived barriers to hypertension self-management [Срок оценки: 6 months]
• Provider engagement as measured by response to study team messages [Срок оценки: 6 months]
• Provider engagement as measured by interactions with participants [Срок оценки: 6 months]
• Care coordination [Срок оценки: 6 months]
• Number of participants with a change in medical therapy [Срок оценки: 6 months]

Критерии участия

Критерии включения

• 18 years old or older
• Uncontrolled hypertension
• History of rheumatoid arthritis
• Receive both primary care and rheumatology care from Duke Health System

Критерии исключения

• Age less than 18 years old
• Healthy volunteers without rheumatoid arthritis and hypertension
• Do not receive both primary care and rheumatology care from Duke Health System
• Cognitive impairment with lack the capacity to consent to study participation
• Pregnant women
• Prisoners

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Не применимо

Модель

Одна группа

Маскирование

Открытое

Основная цель

Лечение

Центры проведения

США · 1 центр

• Duke Health System — Durham

Идентификаторы

NCT: NCT05760898 · PRO00112307 · 3U54MD012530-05S2

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗